FINANCIAL POLICIES FOR RISK MANAGEMENT AND THEIR OBJECTIVES CONTINUED Liquidity risk Less than Two to five one year years Total 2014 $m $m $m Cash and cash equivalents 148 148 Accounts receivable 2 2 Interest-bearing loans and borrowings 253 51 304 Other payables 1 1 104 51 155 Less than Two to five one year years Total 2013 $m $m $m Cash and cash equivalents 4 4 Accounts receivable 2 2 Interest-bearing loans and borrowings 26 141 167 Other payables 1 1 21 141 162 The Company believes that, given the Groups forecast operating cash flow during 2014, it has the ability to satisfy its liability commitments.
STAFF COSTS Hikma Pharmaceuticals PLC currently has 16 employees 2013: 10 excluding Executive Directors : total compensation paid to them amounted to $4 million 2013: $3 million, of which salaries and wages compromise an amount of $3 million 2013: $2 million : the remaining balance of$1 million 2013: $1 million represents national insurance contributions, the cost of share-based payments and other benefits.
STOCK OPTIONS The details of the stock compensation scheme are provided in Note 36.
As at 31 December 2014, the total number of options granted to employees of the Company under the stock compensation scheme during the life of the scheme was 2,560,000 2013: 2,560,000 and the total amount of compensation expenses charged to profit or loss is $nil 2013: $nil.
LONG TERM INCENTIVE PLANS The details of the LTIP scheme are provided in Note 36.
As at 31 December 2014, the total number of awards granted to employees of the Company under the LTIPs during the life of the plans was 1,649,615 shares 2013: 1,521,000 and the total amount of the compensation expenses charged to profit and loss is $2 million 2013: $1 million.
MANAGEMENT INCENTIVE PLANS The details of the MIP scheme are provided in Note 36.
As at 31 December 2014, the total number of awards granted to employees of the Company under the MIP during the life of the plans was 15,834 shares 2013: 10,000 shares and the total amount of the compensation expenses charged to profit and loss is $nil 2013: $nil.
SHARE CAPITAL 2014 2013 Issued and fully paid included in shareholders equity: $m $m 198,632,039 2013: 198,044,328 ordinary shares of 10 pence each 35 35 Details of the issue of share capital in the year are given in Note 31.
SHARE PREMIUM Share premium $m Balance at 1 January 2014 281 Premium arising on exercise of stock options Balance at 31 December 2014 281 169
